Scientists Test New Ways To Regrow Joints Damaged by Arthritis

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2026.

via HealthDay

TUESDAY, April 7, 2026 — Good news: Scientists may be closer to a new way to treat arthritis.

The Advanced Research Projects Agency for Health (ARPA-H) said several experimental treatments could help regrow cartilage and bone in people with osteoarthritis.

The condition affects about 32 million Americans and happens when joints wear down over time.

Three research teams are working on new methods, mainly focused on knee osteoarthritis.

Two teams — one at Duke University and another at University of Colorado Boulder — are developing injections or infusions that may help rebuild cartilage and bone.

A third team at Columbia University is working on a more revolutionary idea: regrowing an entire knee using a 3D-printed “scaffolding” filled with bone and cartilage cells, The New York Times reported.

So far, these methods have only been tested in small animals. Results of animal studies often differ in humans.

Some treatments helped regrow cartilage in just a few months.

One method uses a drug that slowly releases in the joint and helps tissue repair itself over a certain amount of time.

Another method uses proteins that fill in damaged areas and trigger the body to regrow cartilage in spaces where it should be.

“It’s hugely promising,” Dr. Scott Rodeo, vice chair of orthopedic research at the Hospital for Special Surgery in New York City, told The Times. He was not involved with the studies.

“Right now, everything we have just modifies symptoms,” he added. Curing arthritis by regrowing cartilage and bone “would be a paradigm shift.”

These new methods aim to fix the problem right at its source: Damaged cartilage and bone.

Researchers are testing ways to help the body’s own cells grow again.

“I tend to be very skeptical, but this surprised me,” Dr. Benjamin Alman, a pediatric orthopedic surgeon, told The Times.

Some treatments target cartilage, while others focus on remodeling bone or treating multiple joints at once.

Teams funded by ARPA-H are required to begin testing in patients within 18 months, The Times said.

The agency has invested tens of millions of dollars in the work, including more than $42 million for one team alone.

“For academic research, this is like pie-in-the-sky money,” Nadeen Chahine, a leader on the Columbia University team, added.

If the treatments work, they must eventually be made available to patients and priced at no more than 25% of current treatment costs.

Sources

  • The New York Times, April 6, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-08 01:59

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords